Entering text into the input field will update the search result below

Ocular Therapeutix's (OCUL) CEO Antony Mattessich on Q4 2017 Results - Earnings Call Transcript

Mar. 08, 2018 2:11 PM ETOcular Therapeutix, Inc. (OCUL)
SA Transcripts profile picture
SA Transcripts

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q4 2017 Earnings Conference Call March 8, 2018 8:30 AM ET


Donald Notman - CFO

Antony Mattessich - President, CEO & Director

Daniel Bollag - SVP, Regulatory Affairs & Quality

Michael Goldstein - Chief Medical Officer


Blair Cohen - Guggenheim Securities, LLC

William Maughan - Cowen and Company

Dane Leone - BTIG, LLC

Yi Chen - H.C. Wainwright & Co


Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix Q4 and Year-end Earnings Conference Call. [Operator Instructions]. It is now my pleasure to turn the conference over to Mr. Donald Notman, Chief Financial Officer of Ocular Therapeutix. Please go ahead, sir.

Donald Notman

Thank you, Brian. Good morning, everyone, thank you for joining us on our Fourth Quarter and Year-end 2017 Financial Results and Business Update Conference Call. This morning, we issued a press release providing an update on the company's product development programs and details of the company's financial results for the quarter ended December 31, 2017.

The press release can be accessed on the investor's portion of our website at investors.ocutx.com. Before we begin, I would like to lay out a brief agenda for the call. Leading the call today will be Antony Mattessich, our President and Chief Executive Officer, who will provide a summary of our recent clinical and corporate developments; Dr. Dan Bollag, our Senior Vice President of Regulatory Affairs and Quality, will provide an update on our progress in manufacturing and quality systems; Dr. Michael Goldstein, our Chief Medical Officer, will then provide an update on the pipeline.

Following Michael's remarks, I will provide an overview of the financial highlights for the fourth quarter and for the year ended 2017 before turning the call back to Antony for a summary and questions. For

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.